[Validation study of MEP questionnaire for simplified detection of exacerbation of chronic obstructive pulmonary disease]. / Validierungsstudie des MEP-Fragebogens zur erleichterten Erkennung von COPD-Exazerbationen.
Pneumologie
; 76(10): 671-678, 2022 Oct.
Article
em De
| MEDLINE
| ID: mdl-36257306
ABSTRACT
The Questionnaire "Monitoring of Exacerbation Probability" (MEP) provides a novel simple tool to assist detection and semiquantitative numerical documentation of exacerbation (ECOPD) in daily routine. In a prospective multi-center trial involving 3751 visits of 810 patients in 21 centers, MEP was evaluated and compared to the application of the EXACT-Pro questionnaire under real world conditions. The population of COPD patients included in this study is a typical COPD population demographically and clinically. Defining a MEP score of one or more as a positive test result, we found a sensitivity of 91% and a specificity of 66%. Additionally, MEP results correlated clearly with EXACT-Pro results. This qualifies the MEP questionnaire as a valid tool for the detection of ECOPD and longitudinal characterization of COPD patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doença Pulmonar Obstrutiva Crônica
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Limite:
Humans
Idioma:
De
Ano de publicação:
2022
Tipo de documento:
Article